Unlocking the potential: tissue mutation abundance as a predictor for third-generation EGFR-TKI efficacy in NSCLC. Wang R, Wei H, Qu C, Bai Y, et al. Lung Cancer 2025;207:108699.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang R, Wei H, Qu C, Bai Y, et al. Unlocking the potential: tissue mutation abundance as a predictor for third-generation EGFR-TKI efficacy in NSCLC. Lung Cancer 2025;207:108699.
PMID: 40774039